Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ) is now available.
BioDlink International Company Limited, a Hong Kong-incorporated company listed on the Hong Kong Stock Exchange (stock code 1875), announced the composition of its board, comprising an executive director, a non-executive director and three independent non-executive directors. The company has requested a halt in trading of its shares on the Hong Kong Stock Exchange from 9:00 a.m. on 29 December 2025, pending the release of an announcement containing inside information, signaling that potentially price-sensitive developments are forthcoming and placing investors temporarily in a holding pattern until further disclosure is made.
The most recent analyst rating on (HK:1875) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.
More about TOT BIOPHARM International Co. Ltd.
BioDlink International Company Limited is a Hong Kong-incorporated company listed on the Hong Kong Stock Exchange under stock code 1875. The announcement identifies the company’s board composition, including one executive director, one non-executive director and three independent non-executive directors, but does not specify its industry, products or services.
Average Trading Volume: 186,077
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.93B
For an in-depth examination of 1875 stock, go to TipRanks’ Overview page.